Cargando…

Seroprevalence of Wenzhou virus in China

Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pose to humans, we determine the seroprevalence of WENV in heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Guo, Li, Liu, Shasha, Song, Jingdong, Han, Lianlian, Zhang, Hu, Wu, Chao, Wang, Conghui, Zhou, Hongli, Wang, Jianwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Chinese Medical Association Publishing House. Published by Elsevier B.V. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361105/
https://www.ncbi.nlm.nih.gov/pubmed/32838285
http://dx.doi.org/10.1016/j.bsheal.2020.07.004
_version_ 1783559344148709376
author Guo, Li
Liu, Shasha
Song, Jingdong
Han, Lianlian
Zhang, Hu
Wu, Chao
Wang, Conghui
Zhou, Hongli
Wang, Jianwei
author_facet Guo, Li
Liu, Shasha
Song, Jingdong
Han, Lianlian
Zhang, Hu
Wu, Chao
Wang, Conghui
Zhou, Hongli
Wang, Jianwei
author_sort Guo, Li
collection PubMed
description Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pose to humans, we determine the seroprevalence of WENV in healthy individuals in China in this study. Cross-reactivities of nucleoprotein (NP) were detected between Lymphocytic choriomeningitis virus (LCMV) and WENV using Western blot and ELISA assy. The prevalence of specific IgG antibodies against WENV NP was investigated in different age groups of 830 healthy individuals aged 0–70 years old in China using a competition ELISA assay. The results indicate that WENV and LCMV share cross-reactive epitopes between NPs. The total seroprevalence of WENV in healthy adults was 4.6%, with 3.6% (8/221) for individuals 15–44 years of age, 5.4% (17/317) for individuals 45–59 years of age, and 4.1% (4/98) for older adults over 60. The total seroprevalence of WENV in children under age 15 was 1.5%, with 2.9% (1/34) in children aged 2–5 years, and 2.2% in 5–14 years (2/91). The finding suggests that WENV or WENV-like virus may sporadically infect humans of China.
format Online
Article
Text
id pubmed-7361105
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Chinese Medical Association Publishing House. Published by Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-73611052020-07-15 Seroprevalence of Wenzhou virus in China Guo, Li Liu, Shasha Song, Jingdong Han, Lianlian Zhang, Hu Wu, Chao Wang, Conghui Zhou, Hongli Wang, Jianwei Biosaf Health Article Wenzhou virus (WENV) was first identified in rodents and Asian house shrews in Wenzhou, Zhejiang Province, China. However, little is known about the prevalence of WENV infections in humans in China. To determine the threat that WENV may pose to humans, we determine the seroprevalence of WENV in healthy individuals in China in this study. Cross-reactivities of nucleoprotein (NP) were detected between Lymphocytic choriomeningitis virus (LCMV) and WENV using Western blot and ELISA assy. The prevalence of specific IgG antibodies against WENV NP was investigated in different age groups of 830 healthy individuals aged 0–70 years old in China using a competition ELISA assay. The results indicate that WENV and LCMV share cross-reactive epitopes between NPs. The total seroprevalence of WENV in healthy adults was 4.6%, with 3.6% (8/221) for individuals 15–44 years of age, 5.4% (17/317) for individuals 45–59 years of age, and 4.1% (4/98) for older adults over 60. The total seroprevalence of WENV in children under age 15 was 1.5%, with 2.9% (1/34) in children aged 2–5 years, and 2.2% in 5–14 years (2/91). The finding suggests that WENV or WENV-like virus may sporadically infect humans of China. Chinese Medical Association Publishing House. Published by Elsevier B.V. 2020-09 2020-07-15 /pmc/articles/PMC7361105/ /pubmed/32838285 http://dx.doi.org/10.1016/j.bsheal.2020.07.004 Text en © 2020 Chinese Medical Association Publishing House. Published by Elsevier B.V. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Article
Guo, Li
Liu, Shasha
Song, Jingdong
Han, Lianlian
Zhang, Hu
Wu, Chao
Wang, Conghui
Zhou, Hongli
Wang, Jianwei
Seroprevalence of Wenzhou virus in China
title Seroprevalence of Wenzhou virus in China
title_full Seroprevalence of Wenzhou virus in China
title_fullStr Seroprevalence of Wenzhou virus in China
title_full_unstemmed Seroprevalence of Wenzhou virus in China
title_short Seroprevalence of Wenzhou virus in China
title_sort seroprevalence of wenzhou virus in china
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7361105/
https://www.ncbi.nlm.nih.gov/pubmed/32838285
http://dx.doi.org/10.1016/j.bsheal.2020.07.004
work_keys_str_mv AT guoli seroprevalenceofwenzhouvirusinchina
AT liushasha seroprevalenceofwenzhouvirusinchina
AT songjingdong seroprevalenceofwenzhouvirusinchina
AT hanlianlian seroprevalenceofwenzhouvirusinchina
AT zhanghu seroprevalenceofwenzhouvirusinchina
AT wuchao seroprevalenceofwenzhouvirusinchina
AT wangconghui seroprevalenceofwenzhouvirusinchina
AT zhouhongli seroprevalenceofwenzhouvirusinchina
AT wangjianwei seroprevalenceofwenzhouvirusinchina